Company: Valeant Pharmaceuticals International
Valeant Pharmaceuticals International : [VRX
Loading...
()
]
]Thursday, 3 May 2012 | Source: Reuters
(Reuters) - Shares of Valeant Pharmaceuticals International Inc <VRX.TO> <VRX.N> tumbled 9 percent on Thursday after at least one analyst cast doubts about an earnings forecast that initially triggered a sharp rise in the Canadian drug company's shares.
Tuesday, 3 Jan 2012 | Source: The New York Times
Before Europe’s debt crisis flared anew last summer, corporate cash piles and cheap debt had fostered hopes that deal-making would recover strongly. The New York Times reports.
Posts |
COMPANY : Valeant
14 Feb 2012
Posted By:David RussellCNBC Stock Blog
Valeant Pharmaceuticals has been an absolute monster stock for several months, and option traders are betting that the run will continue.... Read More
5 Dec 2011
Posted By:Frank ByrtCNBC Stock Blog
Using research from Morningstar and S&P Capital IQ data, TheStreet.com has picked seven funds that could help investors get healthy returns with a minimal amount of risk to their capital along with a few of their top individual holdings.... Read More
VIDEO | COMPANIES : Valeant Pharmaceuticals International
Jiong Shao, Chief China Strategist, Macquarie, thinks the $7.1 billion Alibaba-Yahoo deal values the Alibaba group too l...
CNBC's Sharon Epperson discusses the day's activity in the commodities markets and looks ahead to where oil and precious...
"I think this is a home run," says Carly Fiorina, former Hewlett-Packard CEO, discussing Facebook's IPO and the emotion...
Robert Hormats, Under Secretary of State provides a preview of the likely topics of discussion at this weekend's G8 meet...
Jay Nelson, Senior Editor, Success Stories: Japan Executive Newsletter, recommends buying Sony shares with a two-year ti...
More Videos
Data is a real-time snapshot *Data is delayed at least 15 minutesGlobal Business and Financial News, Stock Quotes, and Market Data and Analysis
© 2012 CNBC LLC. All Rights Reserved.
